When you look at the sheer numbers, the South Korea Appendicitis Market is pioneering a "Medication First" approach for uncomplicated cases. In 2026, clinical protocols in Seoul and Busan often favor a 10-day course of specialized antibiotics over immediate surgery, provided there are no signs of perforation.

This model is being watched closely by the Spain Appendicitis Market, where researchers are evaluating the long-term recurrence rates of non-surgical patients. While surgery remains the definitive cure in the global Appendicitis Market, the ability to safely avoid an operation is an attractive prospect for healthcare payers looking to reduce the surgical burden on national budgets.

❓ Frequently Asked Questions (FAQ)

1. Does antibiotic treatment always work? A: No, in the South Korea Appendicitis Market, about 20-30% of patients may eventually require surgery within a year.

2. What is the Spanish approach to diagnosis? A: The Spain Appendicitis Market relies on high-resolution MRI to distinguish between complicated and uncomplicated cases.

3. Are there new drugs being developed? A: The Appendicitis Market is seeing a rise in targeted, broad-spectrum intravenous antibiotics for abdominal infections.